Cohen & Steers, Inc. (CNS) — Fair Value Analysis

Base-case fair value (P50): $75.74 · Current price: $84.74 · Verdict: Fairly Valued

The Verdict on CNS

Our Monte Carlo simulations indicate COHEN & STEERS INC (CNS) is currently Fairly Valued. With a current price of $84.74 against a median fair value (P50) of $75.74, CNS shows an -10.6% gap. This narrow difference suggests that CNS's market price is closely aligned with its intrinsic value, as derived from thousands of forward-looking scenarios. For investors evaluating whether CNS presents a compelling entry point, the current valuation suggests a balanced risk/reward profile based on the P50 estimate.

How CNS stacks up against peers

CNS maintains an average quality tier, reflecting its operational and financial health when compared to its sector. This average standing supports the Monte Carlo verdict that CNS is Fairly Valued, rather than significantly over- or undervalued. A company with an average quality tier, trading at $84.74, often sees its median fair value of $75.74 settle close to the market price, as strong operational advantages or significant weaknesses are not driving a large premium or discount. This stability in quality helps anchor the fair value assessment.

What this means for investors

For investors considering COHEN & STEERS INC, the Monte Carlo analysis suggests that CNS is trading near its intrinsic value. The -10.6% from the current price of $84.74 to the median fair value of $75.74 indicates that significant immediate upward or downward movement for a reversion to the P50 is not implied. While this assessment points to CNS being Fairly Valued, individual investors should consider their own risk tolerance and investment horizon. The full range of Monte Carlo simulated outcomes, including detailed bear-case and bull-case scenarios, provides a more comprehensive view of potential price paths. Sign up for a free FairCurve account to see the full bear/bull distribution and track CNS's fair value as new fundamentals are released.